These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12798671)

  • 21. Interaction of felbamate and diazepam against maximal electroshock seizures and chemoconvulsants in mice.
    Gordon R; Gels M; Diamantis W; Sofia RD
    Pharmacol Biochem Behav; 1991 Sep; 40(1):109-13. PubMed ID: 1664105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A neuropharmacological evaluation of felbamate as a novel anticonvulsant.
    White HS; Wolf HH; Swinyard EA; Skeen GA; Sofia RD
    Epilepsia; 1992; 33(3):564-72. PubMed ID: 1592038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamic and pharmacokinetic interaction studies of loreclezole with felbamate, lamotrigine, topiramate, and oxcarbazepine in the mouse maximal electroshock seizure model.
    Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsia; 2005 Mar; 46(3):344-55. PubMed ID: 15730531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcitonin potentiates the anticonvulsant and antinociceptive effects of valproic acid and pregabalin in pentylenetetrazole-kindled mice.
    Hamada NM; Ashour RH; Shalaby AA; El-Beltagi HM
    Eur J Pharmacol; 2018 Jan; 818():351-355. PubMed ID: 29104044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of chronic felbamate administration on anticonvulsant activity and hepatic drug-metabolizing enzymes in mice and rats.
    Swinyard EA; Woodhead JH; Franklin MR; Sofia RD; Kupferberg HJ
    Epilepsia; 1987; 28(3):295-300. PubMed ID: 3107974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative pharmacodynamics and brain distribution of E-delta 2-valproate and valproate in rats.
    Semmes RL; Shen DD
    Epilepsia; 1991; 32(2):232-41. PubMed ID: 2004628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsy.
    Sachdeo R; Narang-Sachdeo SK; Shumaker RC; Perhach JL; Lyness WH; Rosenberg A
    Epilepsia; 1997 Aug; 38(8):887-92. PubMed ID: 9579889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiepileptogenic and anticonvulsive actions of levetiracetam in a pentylenetetrazole kindling model.
    Ohno Y; Ishihara S; Terada R; Serikawa T; Sasa M
    Epilepsy Res; 2010 May; 89(2-3):360-4. PubMed ID: 20138737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiepileptic drugs in development: prospects for the near future.
    Leppik IE
    Epilepsia; 1994; 35 Suppl 4():S29-40. PubMed ID: 8174517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The threshold of pentylenetetrazole-induced convulsive seizures, but not that of nonconvulsive seizures, is controlled by the nitric oxide levels in murine brains.
    Watanabe M; Miyai A; Danjo S; Nakamura Y; Itoh K
    Exp Neurol; 2013 Sep; 247():645-52. PubMed ID: 23499834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of ACEA--a selective cannabinoid CB1 receptor agonist on the protective action of different antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model.
    Andres-Mach M; Zolkowska D; Barcicka-Klosowska B; Haratym-Maj A; Florek-Luszczki M; Luszczki JJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):301-9. PubMed ID: 22789660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of aliskiren, a direct renin inhibitor, on the protective action of antiepileptic drugs against pentylenetetrazole-induced clonic seizures in mice.
    Łukawski K; Raszewski G; Czuczwar SJ
    Fundam Clin Pharmacol; 2019 Apr; 33(2):191-198. PubMed ID: 30312501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of felbamate as add-on therapy to valproic acid in the Lennox-Gastaut syndrome.
    Siegel H; Kelley K; Stertz B; Reeves-Tyer P; Flamini R; Malow B; Gaillard WD; Ko D; Theodore WH
    Epilepsy Res; 1999 Apr; 34(2-3):91-7. PubMed ID: 10210023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate.
    Sachdeo R; Wagner ML; Sachdeo S; Shumaker RC; Lyness WH; Rosenberg A; Ward D; Perhach JL
    Epilepsia; 1999 Aug; 40(8):1122-8. PubMed ID: 10448826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between lamotrigine and felbamate in the maximal electroshock-induced seizures in mice: an isobolographic analysis.
    Luszczki JJ; Czuczwar SJ
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):133-42. PubMed ID: 15695057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticonvulsant activity of felbamate in amygdala kindling model of temporal lobe epilepsy in rats.
    Wlaź P; Löscher W
    Epilepsia; 1997 Nov; 38(11):1167-72. PubMed ID: 9579916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Felbamate in the treatment of refractory partial-onset seizures.
    Jensen PK
    Epilepsia; 1993; 34 Suppl 7():S25-9. PubMed ID: 8243375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis.
    Luszczki JJ; Wojcik-Cwikla J; Andres MM; Czuczwar SJ
    Neuropsychopharmacology; 2005 May; 30(5):958-73. PubMed ID: 15525996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticonvulsant effect of felbamate in the pentylenetetrazole kindling model of epilepsy in the rat.
    Giorgi O; Carboni G; Frau V; Orlandi M; Valentini V; Feldman A; Corda MG
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):173-8. PubMed ID: 8857594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of calcium channel blockers on anticonvulsant and antinociceptive activities of valproic acid in pentylenetetrazole-kindled mice.
    El-Azab MF; Moustafa YM
    Pharmacol Rep; 2012; 64(2):305-14. PubMed ID: 22661180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.